Table of Contents
(Source: Heart and Lung)
Source: Heart and Lung - April 6, 2024 Category: Intensive Care Source Type: research
Board of Directors
(Source: Heart and Lung)
Source: Heart and Lung - April 6, 2024 Category: Intensive Care Source Type: research
Year of the patient and Caregiver
The American Association of Heart Failure Nurses (AAHFN) promoted another successful Heart Failure Awareness Week in February 2024. AAHFN celebrates Heart Failure Awareness Week each year with a theme directed towards heart failure patients and/or Caregivers. This year's theme is Patients& Caregivers: Empowering Patients with Knowledge and Hope. We hosted our first virtual, live Patient& Caregiver Day. It was an afternoon of engaging speakers with timely topics related to living with heart failure. (Source: Heart and Lung)
Source: Heart and Lung - March 29, 2024 Category: Intensive Care Authors: Tara Whitmire Source Type: research
Effects of bradycardia, hypoxemia and early intubation on bronchopulmonary dysplasia in very preterm infants: An observational study
In 2020, approximately 13.4 million infants were born prematurely, representing a rate of more than 1 in 10 infants.1 Although the global birth rate declined to 17.668 ‰ in 2022,2 preterm birth rates have not changed over the past decade. Because of their immaturity, preterm infants’ survival depends on advanced neonatal intensive care, which can maintain these infants under stable conditions, providing for their continuous growth and development. Preterm infa nts may face lifelong health consequences and have a higher likelihood of disability and morbidity. (Source: Heart and Lung)
Source: Heart and Lung - March 11, 2024 Category: Intensive Care Authors: Yu-Ting Chen, Hsiang-Yun Lan, Yu-Lun Tsai, Hsiang-Ping Wu, Jen-Jiuan Liaw, Yue-Cune Chang Source Type: research
Dietary antioxidant intake is associated with heart failure: Results from the NHANES 2003 –2019
Alongside the accelerating aging of the population, there is an increasing number of people with coronary heart disease, hypertension, diabetes, and obesity, as well as improvements in medical care, which lead to the longer life expectancy of people with heart disease; these factors all contribute to the increasing prevalence of heart failure (HF).1-4 In 2019, more than 29.7 million people worldwide suffered from HF, with this number expected to rise to 38.7 million by 2030.5 In highly developed countries, like the United States, HF affects 6.578 million people. (Source: Heart and Lung)
Source: Heart and Lung - March 8, 2024 Category: Intensive Care Authors: Tao Li, Huangdan Yang, Lijuan Guo, Zeya Shi, Wanqin Hu Source Type: research
Association between carotenoids and the prevalence of chronic obstructive pulmonary disease in the United States
Chronic obstructive pulmonary disease (COPD) is a prevalent respiratory condition characterized by persistent respiratory symptoms and restricted airflow resulting from exposure to harmful particles and gases.1 Chronic bronchitis and emphysema are the two main characteristics of COPD due to abnormalities in the airways or alveoli.2 COPD is a major reason for hospital admission and has been a public health issue.3 Several studies have revealed that inflammation plays a pivotal role in the development of COPD. (Source: Heart and Lung)
Source: Heart and Lung - March 7, 2024 Category: Intensive Care Authors: Qiong Huang, Zhenyu Peng, Siqi Li, Wenbin Nan, Baimei He Source Type: research
Predictors of quality of life in primary caregivers of patients with heart failure: A model of health literacy and caregiving burden
Heart Failure (HF) is a complex clinical syndrome that affects the health of more than 64 million people worldwide,1 and there are about 8.9 million patients with HF in China.2 The prevalence of heart failure is projected to increase in the future due to China's aging population, rising cardiovascular risk factors (coronary heart disease, diabetes, obesity), and advancements in therapeutic and diagnostic technologies that enhance survival rates.3 Symptoms such as dyspnea and weakness due to HF, unpredictable acute exacerbations and hospitalizations due to HF, and medication burdens and side effects can lead to the over-dep...
Source: Heart and Lung - March 5, 2024 Category: Intensive Care Authors: Chunli Zhao, Xiuying Lu, Yunying Li, Juan Li, Yuling Gao Source Type: research
Association of the oxidation balance score with the prevalence of chronic obstructive pulmonary disease from the NHANES 2007 –2012: A large-scale cross-sectional study
As one of the leading causes of mortality from noncommunicable diseases worldwide, chronic respiratory diseases have emerged as the third leading cause of mortality, following cardiovascular disease and cancer. Due to its high incidence and poor prognosis, chronic respiratory diseases bring different degrees of disease and economic burden to various countries around the world.1,2 Among all chronic respiratory diseases, chronic obstructive pulmonary disease (COPD) has attracted attention with its highest incidence. (Source: Heart and Lung)
Source: Heart and Lung - March 5, 2024 Category: Intensive Care Authors: Ziyi Liu, Hongbo Zeng, Hongliang Zhang Source Type: research
Corticosteroid in non-COVID-19 induced community-acquired pneumonia, a meta-analysis
Community-acquired pneumonia (CAP) is a significant global health burden with high incidence and mortality worldwide.1-4 Systemic corticosteroids possess broad-spectrum anti-inflammatory effects, and the controversy over their adjunctive treatment in CAP has persisted for decades.1 The benefits of corticosteroid use have been confirmed in patients with severe CAP (sCAP) caused by COVID-19.5,6 However, the role of corticosteroids in non-COVID-19 induced CAP remains uncertain.1,4,7-9 (Source: Heart and Lung)
Source: Heart and Lung - March 2, 2024 Category: Intensive Care Authors: Jian Liu, Yongquan Dong, Jia Chen, Yuqing Jin, Yunqing Qiu, Lingtong Huang Source Type: research
Association of serum albumin with heart failure mortality with NYHA class IV in Chinese patients: Insights from PhysioNet database (version 1.3)
Heart failure (HF), designated as a new epidemic since 1997, is a highly prevalent and progressive disease worldwide, and now is still a major clinical and public health problem.1-3 HF is a chronic clinical syndrome, characterized by dyspnea, fatigue, elevated natriuretic peptide, and impaired cardiac function.4,5 Data convincingly shows that the mortality rate of heart failure has begun to rise in the decade,6-8 and in particular, the burden of mortality and hospitalization of severe HF has not been reduced though the decline in incidence rate. (Source: Heart and Lung)
Source: Heart and Lung - March 2, 2024 Category: Intensive Care Authors: Yun Chen, Xian-Bin Cai, Xin Yao, Shao-Hui Zhang, Min-Hua Cai, Hao-Peng Li, Xu-Bin Jing, Yong-Gang Zhang, Qia-Feng Ding Source Type: research
Table of Contents
(Source: Heart and Lung)
Source: Heart and Lung - March 1, 2024 Category: Intensive Care Source Type: research
Board of Directors
(Source: Heart and Lung)
Source: Heart and Lung - March 1, 2024 Category: Intensive Care Source Type: research
Phenotyping cardiopulmonary exercise testing measures in heart failure with reduced ejection fraction: A comparison between Italy and Brazil
Cardiovascular disease continues to be a leading cause of premature mortality globally. Among cardiovascular conditions, heart failure (HF) with reduced left ventricular ejection fraction (HFrEF), representing advanced pathophysiology, is particularly disconcerting from both the perspective of high prevalence and unfavorable long-term prognosis.1 (Source: Heart and Lung)
Source: Heart and Lung - February 24, 2024 Category: Intensive Care Authors: C ássia da Luz Goulart, Piergiuseppe Agostoni, Elisabetta Salvioni, Rebeca Nunes Silva, Daniela Bassi-Dibai, Meliza Goi Roscani, Ross Arena, Jonathan Myers, Audrey Borghi-Silva Source Type: research
Effects of daily sleep on physical activity after cardiac surgery
Maintaining physical activity is essential for adults who have undergone cardiac surgery,1 such as coronary artery bypass graft (CABG), heart valve repair or replacement, aortic surgery, arrhythmia surgery, and myectomy. Lower levels of physical activity are associated with a higher risk of postoperative complications after cardiac surgery,2 whereas adequate activity can prevent secondary cardiovascular events3 and reduce long-term mortality.4 However, maintaining physical activity after cardiac surgery is challenging. (Source: Heart and Lung)
Source: Heart and Lung - February 23, 2024 Category: Intensive Care Authors: Sueyeon Lee, Lauretta Quinn, Cynthia Fritschi, Anne M. Fink, Chang Park, Sirimon Reutrakul, Eileen G. Collins Source Type: research
A qualitative study of the experiences and perceptions of older patients and relatives prior to cardiac surgery
Improved surgical treatment techniques and prevention strategies have led to an increase in life expectancy in industrialised countries.1 As a result, the number of older adults with cardiovascular diseases is projected to increase, as is the proportion of patients undergoing cardiac surgery who have multimorbidities, such as chronic obstructive pulmonary disease (COPD), renal failure, or reduced cognitive function.1,2 Both increased age and multimorbidities increase an individual's frailty, meaning they are less resilient to stressors. (Source: Heart and Lung)
Source: Heart and Lung - February 22, 2024 Category: Intensive Care Authors: Milou S.H. van Die ën, Wolter Paans, Massimo A. Mariani, Willem Dieperink, Fredrike Blokzijl Source Type: research
